X4 pharmaceuticals chief commercial officer Mark Baldry acquires $19,251 in stock
In recent transactions disclosed by X4 Pharmaceuticals, Inc. (NASDAQ:XFOR), Chief Commercial Officer Mark Baldry has made significant stock acquisitions amid the company's current $85.6 million market ...